Kurser indlæses...

Prognose

Vi har ingen analytikerdata for denne virksomhed.

Nyheder Til nyhedsfeedet

Alcidion reports record 2026 and forecasts growth for 2027 — shares rise 8%

Alcidion recorded a 27% revenue increase in fiscal 2026 to AUD 51.6m, an ARR of AUD 38.3m (+34%) and a record total contract value of AUD 78.5m. The company generated positive operating cash flow (AUD 6.8m), finished the year debt-free with AUD 20.6m in cash and reported an adjusted EBITDA of AUD 6.8m. Shares rose about 8% after the results, as management expects both revenue and adjusted EBITDA in 2027 to exceed 2026 levels and already cites sold/renewed revenue of AUD 44.9m. Risks remain the timing of large contract wins, margin pressure on capital licences and competitive pressure in the UK. » Mere på de.investing.com
Alcidion achieves best Q1 in two years with $8.2m in new contracts

In Q1 2025 Alcidion reported its strongest performance in two years with $8.2m in new contracts. Operating cash outflow fell sharply from $4m to $600,000, the cash balance is $16.4m and the company is debt-free. Contracted revenue for 2026 stands at $36.3m, and Alcidion confirms guidance for positive EBITDA and operating cash flow. Management is examining market entries in Saudi Arabia and Canada for international expansion; the share last fell 1.05% to $0.094. » Mere på de.investing.com
Alcidion benefits from strong cash flow and order growth in Q4 2025

Alcidion recorded a record increase in new orders and positive operating cash flow in the fourth quarter of 2025, which drove the share price up by 12.5%. The company is well positioned for further growth with $17.7 million in liquidity and no debt, and expects EBITDA of over $4.5 million for fiscal year 2025. Risks include potential delays in implementations and challenges in expanding into new markets. » Mere på de.investing.com

Historisk udbytte Udbytte

Alle nøgletal for udbytte Alle nøgletal

I 2022 har ALCIDION GROUP LTD allerede udloddet 0,0717 € i udbytte. Den seneste udlodning fandt sted i juli 2022.

Virksomhedstal

I det seneste kvartal havde ALCIDION GROUP LTD en omsætning på 15,85 mio. € og et nettoresultat på 578,38 t €

(EUR)	juni 2026	YoY
Omsætning	15,85 mio.	-
Bruttofortjeneste	2,46 mio.	-
Nettoresultat	578,38 t	-
EBITDA	212,58 t	-

Fundamentale data

Nøgletal	Værdi
Markedsværdi	87,52 mio. €
Antal aktier	1,35 mia.
Højeste/laveste i 52 uger	0,0895 € - 0,0513 €
Udbytte	Nej
Beta	1,02
P/E (PE Ratio)	61,76
PEG (PEG Ratio)	1,48
K/I (PB Ratio)	1,55
P/S (PS Ratio)	2,74

Virksomhedsprofil

Alcidion Group Limited udvikler og licenserer sammen med sine datterselskaber softwareprodukter til sundhedssektoren i Australien, New Zealand og Storbritannien. Virksomheden tilbyder Miya Precision, en konsolideret FHIR-baseret (Fast Healthcare Interoperability Resources) platform til at levere intelligent sundhedspleje; Smartpage, et smartphone- og webbaseret system til kommunikation og opgavestyring på hospitaler, som imødekommer behovene hos både kliniske og ikke-kliniske brugere; Patientrack, en løsning til realtidsovervågning af patienter og risikoscreening; og ExtraMed, en software til styring af patientflow. Virksomheden leverer desuden implementering af produkter, produktsupport og vedligeholdelse, systemintegration og dataanalyseydelser. Virksomheden var tidligere kendt som Alcidion Corporation Pty Ltd og skiftede navn til Alcidion Group Limited i december 2015. Alcidion Group Limited blev grundlagt i 2000 og har hovedkontor i South Yarra, Australien.